Retension Pharmaceuticals (RTSN) vs Telomir Pharmaceuticals (TELO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 12, 2026.
Summary
Retension Pharmaceuticals is the larger company by market cap ($89.2 million vs $81.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | RTSN | TELO |
|---|---|---|
| Share price | $11.32 | $1.10 |
| Market cap | $89.22M | $80.98M |
| 1-day change | +7.50% | -1.79% |
| YTD return | — | -15.79% |
| 1-year return | — | -30.00% |
| EPS (TTM) | $-2.61 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.79 | $1.75 |
| 52-week low | $9.66 | $0.888 |
| Distance from 52-week high | -3.99% | -37.14% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +263.64% |
| Average volume | 789.20K | 98.53K |
| Shares outstanding | 7.88M | 73.62M |
| Employees | 12 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Retension Pharmaceuticals
RTSN stock →Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About Telomir Pharmaceuticals
TELO stock →Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria.
Health Care · Biotechnology: Pharmaceutical Preparations
RTSN vs TELO FAQ
Which is bigger, Retension Pharmaceuticals or Telomir Pharmaceuticals?
Retension Pharmaceuticals (RTSN) is larger, with a market capitalization of $89.22M compared with $80.98M for Telomir Pharmaceuticals (TELO).
Are Retension Pharmaceuticals and Telomir Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.